These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 28499957)

  • 1. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of skin and skin structure infections due to Gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT).
    Mirón-Rubio M; Parra Jordán JJ; González Ramallo VJ; Mujal Martínez A; Fernández Muixí J; Iglesias Gallego M; Lucas Núñez MC; Rodado Alabau E; Vidal Perez-Campoamor S; Uría E
    Rev Esp Quimioter; 2023 Jun; 36(3):291-301. PubMed ID: 37017118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
    Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
    Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
    Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
    Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
    Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
    Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.
    Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J
    Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease.
    Ponce González MA; Mirón Rubio M; Mujal Martinez A; Estrada Cuxart O; Fiuza Perez D; Salas Reinoso L; Fernández Fabrellas E; Chiner Vives E
    Int J Clin Pract; 2017 Dec; 71(12):. PubMed ID: 28949430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
    Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
    Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
    Dimitrova M; Gilchrist M; Seaton RA
    BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry.
    Mirón-Rubio M; González-Ramallo V; Estrada-Cuxart O; Sanroma-Mendizábal P; Segado-Soriano A; Mujal-Martínez A; Del Río-Vizoso M; García-Lezcano M; Martín-Blanco N; Florit-Serra L; Gil-Bermejo M
    Future Microbiol; 2016; 11(3):375-90. PubMed ID: 26974259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
    Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
    Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.